参考文献/References:
[1] Heldner MR,Zubler C,Mattle HP,et al.National institutes of health stroke scale score and vessel occlusion in 2152 patients with acute ischemic stroke[J].Stroke,2013,44(4):1153-1157.
[2] Wolf PA,Abbott RD,Kannel WB.Atrial fibrillation as an Independent risk factor for stroke: the Framingham Study[J].Stroke,1991,22(8):983-988.
[3] Stewart S,Hart CL,Hole DJ,et al.Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study[J].Heart,2001,86(5):516-521.
[4] European Atrial Fibrillation Trial Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke[J]. Lancet, 1993, 342(8882): 1255-1262.
[5] Ntaios G,Papavasileiou V,Diener HC,et al.Nonvitamin-K-antagonist oral anticoagulants in patients with atrial fibrillation and previous stroke or transient ischemic attack: a systematic review and meta-analysis of randomized controlled trials[J].Stroke,2012,43(12):3298-3304.
[6] Hart RG,Pearce LA,Aguilar MI.Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation[J].Ann Intern Med,2007,146(12):857-867.
[7] Suissa L,Bertora D,Lachaud S,et al.Score for the targeting of atrial fibrillation(STAF): a new approach to the detection of atrial fibrillation in the secondary prevention of ischemic stroke[J].Stroke,2009,40(8):2866-2868.
[8] Malik S,Hicks WJ,Schultz L,et al.Development of a scoring system for atrial fibrillation in acute stroke and transient ischemic attack patients: the LADS scoring system[J].J Neurol Sci,2011,301(1/2):27-30.
[9] Horstmann S,Rizos T,Güntner J,et al.Does the STAF score help detect paroxysmal atrial fibrillation in acute stroke patients[J]?European Journal of Neurology,2013,20(1):147-152.
[10] 刘小艳,黎泳欣,徐安定,等.STAF评分在缺血性卒中患者心房颤动筛查的应用[J].中国神经精神疾病杂志,2013,39(9):534-537.
[11] 中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2010[J].中华医学信息导报,2010,25(14):16-19.
[12] Adams HJ,Bendixen BH,Kappelle LJ,et al.Classification of subtype of acute ischemic stroke.Definitions for use in a multicenter clinical trial.TOAST.Trial of Org 10172 in Acute Stroke Treatment[J].Stroke,1993,24(1):35-41.
[13] O'donnell MJ,Xavier D,Liu L,et al.Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries(the INTERSTROKE study): a case-control study[J].Lancet,2010,376(9735):112-123.
[14] Adams HP, Woolson RF, Helgason C, et al. Low molecular weight heparinoid, ORG 10172(Danaparoid), and outcome after acute ischemic stroke-A randomized controlled trial[J]. JAMA, 1998, 279(16): 1265-1272.
[15] Kolominsky-Rabas PL,Weber M,Gefeller O,et al.Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study[J].Stroke,2001,32(12):2735-2740.
[16] Wang Y,Liao X,Zhao X,et al.Using recombinant tissue plasminogen activator to treat acute ischemic stroke in China: analysis of the results from the Chinese National Stroke Registry(CNSR)[J].Stroke,2011,42(6):1658-1664.
[17] Gladstone DJ,Spring M,Dorian P,et al.Atrial fibrillation in patients with cryptogenic stroke[J].N Engl J Med,2014,370(26):2467-2477.
[18] Miller DJ,Khan MA,Schultz LR,et al.Outpatient cardiac telemetry detects a high rate of atrial fibrillation in cryptogenic stroke[J].J Neurol Sci,2013,324(1/2):57-61.
[19] Sposato LA,Cipriano LE,Saposnik G,et al.Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis[J].The Lancet Neurology,2015,14(4):377-387.
[20] Kernan WN,Ovbiagele B,Black HR,et al.Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American heart association/American stroke association[J].Stroke,2014,45(7):2160-2236.